Skip to main content
OpenTrials
Completed

NCT Number: NCT01707862

Surgery for Intravenous Leiomyomatosis

Intravenous leiomyomatosis (IVL) with intracardiac extension is a rare benign smooth muscle tumor. Reviewing literature, intracardiac extension of the IVL has been reported in at least 70 cases. Most are individual case reports. Surgical experience is not much. However, different opinion of surgical strategies remain controversial. The purpose of this report is to describe our experience of surgical management for the IVL with intracardiac extension.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

Female

Study type

Observational

Primary location

Institute of Cardiovascular Disease

Beijing, China

About this study

All patients underwent surgical management. Clinical data were obtained from medical reports. Following-up was made through email and telephone.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age more than 18 years.
  • Tumor markers were all within normal limits.
  • Patients underwent surgical management.
  • Patients were followed-up for more than 12 months.

Exclusion criteria

-Tumor markers were all within abnormal limits

Sponsors and collaborators

Lead sponsor

Li Yang

Other

Registry information

Official study title

Surgical Management of Intravenous Leiomyomatosis With Intracardiac Extension: Our Experience and Outcomes

Acronym: SIVL

Important dates

Study start
1997
Primary completion
2012
Study completion
2012
First posted
Oct 16, 2012
Registry last updated
Oct 16, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.